ENSGALG00000025747


Gallus gallus
activitybindingNQO2electronionoxidoreductasecompoundsflavodoxin-likefoldflavoprotein-likesuperfamilytransportchainoxidation-reductionprocessnucleoplasmcytosoldihydronicotinamideribosidequinonereductasezinctransferactingnitrogenousdonorschlorideproteinhomodimerizationfadmelatonin

Features
Gene ID: ENSGALG00000025747
  
Biological name :NQO2
  
Synonyms : NQO2 / N-ribosyldihydronicotinamide:quinone reductase 2
  
Possible biological names infered from orthology : P16083 / Q9JI75
  
Species: Gallus gallus
  
Chr. number: 2
Strand: -1
Band:
Gene start: 66585724
Gene end: 66594379
  
Corresponding Affymetrix probe sets: Gga.11743.2.S1_a_at (Chicken Array)   
  
Cross references: Ensembl peptide - ENSGALP00000043073
NCBI entrez gene - 420886     See in Manteia.
RefSeq - XM_418973
swissprot - R4GLI9
Ensembl - ENSGALG00000025747
  
See expression report in BioGPS
See gene description in Wikigenes
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 NQO2ENSG00000124588Homo sapiens
 Nqo2ENSMUSG00000046949Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
NQO1 / NAD(P)H dehydrogenase / P15559* / Q64669* / NAD(P)H quinone dehydrogenase 1* / NAD(P)H dehydrogenase [quinone] 1 *ENSGALG0000002343748


Protein motifs (from Interpro)
Interpro ID Name
 IPR003680  Flavodoxin-like fold
 IPR029039  Flavoprotein-like superfamily


Gene Ontology (GO)
cellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processoxidation-reduction processcellular metabolic processcellular metabolic processoxidation-reduction processoxidation-reduction process
oxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductase activityion bindingprotein bindingorganic cyclic compound bindingheterocyclic compound bindingcofactor bindingsmall molecule bindinghormone bindingamide bindingdrug bindingoxidoreductaseoxidoreductase activityion bindingion bindingprotein bindinprotein bindingorganic cyclicorganic cyclic compound bindingheterocyclic cheterocyclic compound bindingcofactor bindicofactor bindingsmall moleculesmall molecule bindinghormone bindinhormone bindingamide bindingamide bindingdrug bindingdrug binding
cellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellorganellemembrane-enclosed lumencellcellorganelleorganellemembrane-enclosed lumenmembrane-enclosed lumen
TypeGO IDTermEv.Code
 biological_processGO:0022900 electron transport chain IEA
 biological_processGO:0055114 oxidation-reduction process IEA
 cellular_componentGO:0005654 nucleoplasm IEA
 cellular_componentGO:0005829 cytosol IEA
 molecular_functionGO:0001512 dihydronicotinamide riboside quinone reductase activity IEA
 molecular_functionGO:0008270 zinc ion binding IEA
 molecular_functionGO:0009055 electron transfer activity IEA
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0016661 oxidoreductase activity, acting on other nitrogenous compounds as donors IEA
 molecular_functionGO:0031404 chloride ion binding IEA
 molecular_functionGO:0042803 protein homodimerization activity IEA
 molecular_functionGO:0071949 FAD binding IEA
 molecular_functionGO:1904408 melatonin binding IEA
 molecular_functionGO:1905594 resveratrol binding IEA


Pathways (from Reactome)
Pathway description
Phase I - Functionalization of compounds


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
No match
  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSGALG00000025747 NQO2 / N-ribosyldihydronicotinamide:quinone reductase 2 / P16083* / Q9JI75*  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   

© Olivier Tassy / Olivier Pourquie 2007-2025
contact: otassy@igbmc.fr